Increased focus on generics and biologics and regulatory approvals in emerging markets generate huge potential

DUBLIN, July 26, 2022 /PRNewswire/ — The “Clinical Trial Supply and Logistics for Pharmaceutical Market Research Report by Phase (BA/BE Studies, Phase I and Phase II), Sector, Therapeutic Area, Region (Americas, Asia Pacificand Europe, Middle East & Africa) – Global Forecast to 2027 – Cumulative Impact of COVID-19″ report has been added to from offer.

The global clinical trial supply and logistics market size for pharmaceuticals has been estimated at $18,213.74 million in 2020, $19,607.86 million in 2021, and is expected to grow at a compound annual growth rate (CAGR) of 7.69% to reach $30,593.72 million by 2027.

Market dynamics

  • Increase in R&D expenditure of the pharmaceutical and biopharmaceutical industry
  • Increased focus on drug development
  • Globalization of clinical trials and harmonization of regulations


  • Increased cost of drug development and clinical trials


  • Outsourcing of clinical trial activity
  • Increased focus on generics and biologics
  • Regulatory approvals in emerging markets


  • Logistic challenges across nations

Segmentation and market coverage:
This research report categorizes clinical trial supply and logistics for the pharmaceutical industry to forecast revenue and analyze trends in each of the following submarkets:

  • On the basis of phase, the market has been studied in BA/BE studies, phase I, phase II, phase III and phase IV.
  • Based on the sector, the market has been studied into clinical trial logistics and distribution, clinical trial manufacturing services, and clinical trial supply chain management.
  • Based on therapeutic area, the market has been studied in blood disorders, digestive system diseases, infectious and immune system diseases, neurological and mental disorders, and oncology.

Competitive Strategy Window:
The strategic competitive window analyzes the competitive landscape in terms of markets, applications and geographies to help the vendor define an alignment or match between its capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for vendors to adopt successive strategies of merger and acquisition, geographic expansion, research and development, and new product introduction strategies to execute further business expansion and growth. during a forecast period.

FPNV positioning matrix:
The FPNV Positioning Matrix assesses and categorizes vendors in the Clinical Trial Supply and Logistics for Pharmaceuticals market based on business strategy (business growth, industry coverage, financial viability, and market capture). support channels) and product satisfaction (value for money, ease of use, product features, and customer support) that helps businesses make better decisions and understand the competitive landscape.

Market share analysis:
The market share analysis offers the analysis of the vendors considering their contribution to the overall market. It gives the idea of ​​its revenue generation in the overall market compared to other providers in the space. It provides information on the performance of vendors in terms of revenue generation and customer base compared to others. Knowing the market share gives an idea of ​​the size and competitiveness of suppliers for the reference year. It reveals the characteristics of the market in terms of accumulation, fragmentation, dominance and merger.

Competitive scenario:
The competitive scenario provides an analysis of the prospects of the different business growth strategies adopted by the vendors. The news covered in this section provides valuable insights at various stages while keeping abreast of business news and engaging stakeholders in the economic debate. The competitive scenario represents press releases or company news categorized into merger and acquisition, agreement, collaboration and partnership, new product launch and improvement, investment and funding, and awards, recognition and expansion. All the news gathered helps the vendor to understand the gaps in the market and the strength and weakness of the competitors, thus providing insights to improve the product and service.

Main topics covered:

1. Preface

2. Research methodology

3. Executive Summary

4. Market Overview

5. Market Overview

6. Clinical trial supply and logistics for the pharmaceutical market, by phase

7. Clinical trial supply and logistics for the pharmaceutical market, by sector

8. Clinical trial procurement and logistics for the pharmaceutical market, by therapeutic area

9. Americas Clinical Trial Supply and Logistics for Pharmaceutical Market

10. Asia-Pacific clinical trial supply and logistics for the pharmaceutical market

11. Europe, Middle East & Africa Supply and logistics of clinical trials for the pharmaceutical market

12. Competitive landscape

13. Enterprise Usability Profiles

14. Appendix

Companies cited

  • Almac Group
  • Bilcare Limited
  • Biocair International Limited
  • Catalent, Inc.
  • Clinicen Group PLC
  • DHL International GmbH by Deutsche Post AG
  • Eurofins Scientific SE
  • FedEx Corporation
  • infosys limited
  • Lonza Group
  • Brand
  • Metrics Contract Services by Mayne Pharma Group
  • Movianto
  • N side
  • PCI Pharmacy Services
  • Parexel International Corporation
  • SIRO Clinpharm Private Limited
  • Seveillar Clinical Trial Supplies Pvt. ltd.
  • ThermoFisher Scientific, Inc.
  • UDG Healthcare PLC
  • Global Courier Management Inc.

For more information on this report, visit

Media Contact:

Research and Markets
Laura Woodsenior
[email protected]

For EST office hours, call +1-917-300-0470
For USA/CAN call toll free +1-800-526-8630
For GMT office hours call +353-1-416-8900

US Fax: 646-607-1907
Fax (outside the US): +353-1-481-1716


SOURCE Research and Markets